Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor and Ataluren for Cystic Fibrosis
NCT03256799Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivacaftor in cystic fibrosis (CF), sponsored by University of Alabama at Birmingham. Started Mar 2017; status: completed.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03256799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256799.